Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Express Scripts Holding Co. (NASDAQ: ESRX).

Full DD Report for ESRX

You must become a subscriber to view this report.


Recent News from (NASDAQ: ESRX)

Merger Arbitrage In One Place
This is a starting post in a new series that is eventually expected to cover wide range of special situations across various geographies. Daily/weekly post will include any new actionable deals as well as updates on existing cases. I will start with the easiest to follow - Merger Arbitrag...
Source: SeekingAlpha
Date: September, 07 2018 12:25
WSJ: DoJ nearing antitrust OK of CVS-Aetna, Cigna-Express Scripts mergers
Justice Department antitrust enforcers are preparing to approve CVS Health's (NYSE: CVS ) planned acquisition of Aetna (NYSE: AET ) and Cigna's (NYSE: CI ) planned purchase of Express Scripts (NASDAQ: ESRX ) within the next few weeks, WSJ reports. More news on: CVS Health Corporat...
Source: SeekingAlpha
Date: September, 05 2018 17:50
Small Caps Are Rising, Biotechs Can't Be Far Behind
Market Pulse The S&P 500 has finally emerged from its 7-month consolidation as it weaves its way back to chalking all-time highs. While that is an event worth acknowledging, it may not be as breathless a milestone when one realizes that the small cap Russell 2000 index led the market and...
Source: SeekingAlpha
Date: September, 05 2018 13:31
Inside Rx® Prescription Savings Card Boosts Deep Discounts on Brand-Name Medications to more than 130 Drugs
FRANKLIN LAKES, N.J. , Sept. 5, 2018 /PRNewswire/ -- Inside Rx, LLC, a partially owned subsidiary of Express Scripts (NASDAQ:ESRX), today announced it added 14 new medications to its brand medications listing for the Inside Rx® prescription savings card. The program now offers d...
Source: PR Newswire
Date: September, 05 2018 09:00
Merger Arbitrage Mondays - September 3, 2018
Merger activity remained unchanged last week with three new deals announced and three pending deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. There were two new deals announced in the Deals i...
Source: SeekingAlpha
Date: September, 04 2018 04:10
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2018 Update
This article is part of a series that provides an ongoing analysis of the changes made to Larry Robbins' 13F portfolio on a quarterly basis. It is based on Robbins' regulatory 13F Form filed on 08/14/2018. Please visit our Tracking Larry Robbins' Glenview Capital Management Portfolio artic...
Source: SeekingAlpha
Date: September, 03 2018 12:05
23andMe cuts off app developers from raw genetic data
Privately held 23andMe has informed outside app developers that they will no longer have access to its raw genomic data, one of the largest datasets in the world. More news on: GlaxoSmithKline, Health Care Select Sect SPDR ETF, iShares Nasdaq Biotechnology ETF, Healthcare stocks news, Te...
Source: SeekingAlpha
Date: August, 24 2018 13:00
Express Scripts Stockholders Approve Acquisition by Cigna
ST. LOUIS , Aug. 24, 2018 /PRNewswire/ -- Stockholders of Express Scripts Holding Company (NASDAQ: ESRX) today approved the proposed acquisition of Express Scripts by Cigna. Based on a preliminary tabulation, approximately 78 percent of the shares of Express Scripts commo...
Source: PR Newswire
Date: August, 24 2018 10:53
Powell To Center Stage In Jackson Hole (Wall Street Breakfast Podcast)
Editor's note: Seeking Alpha is proud to welcome WSB Podcast as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more » Today's top ...
Source: SeekingAlpha
Date: August, 24 2018 07:36
Wall Street Breakfast: Powell To Center Stage In Jackson Hole
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on iTunes , Stitcher and SoundCloud (click the highlighted links). Federal Reserve Chairman Jerome Powell is due to give a speech about monetary policy in a changing economy at the ...
Source: SeekingAlpha
Date: August, 24 2018 06:15

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0890.1090.8091.0389.464,536,458
2018-05-1773.5976.3576.9273.5156,019,727
2017-02-0268.7366.6968.8365.828,891,702
2017-02-0168.6569.1169.151968.013,597,957
2017-01-3167.7868.8868.8967.304,226,880

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-14528,6952,486,85421.2596Cover
2018-12-13343,9601,859,29018.4995Cover
2018-12-12101,568593,98917.0993Cover
2018-12-11127,320356,72035.6919Short
2018-12-1094,393247,99338.0628Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ESRX.


About Express Scripts Holding Co. (NASDAQ: ESRX)

Logo for Express Scripts Holding Co. (NASDAQ: ESRX)

Not available

 

Contact Information

 

 

Current Management

  • George Paz / President, CEO
  • Edward J. Stiften / CFO, Senior VP
  • Thomas M. Boudreau / Secretary, Senior VP, Chief Legal Officer
  • George Paz / Chairman

Current Share Structure

  • Market Cap: $35,505,140,720 - 05/15/2018
  • Issue and Outstanding: 484,778,000 - 01/31/2012

 


Recent Filings from (NASDAQ: ESRX)

Filing of certain prospectuses and communications in connection with business combination transactions
Filing Type: 425Filing Source: edgar
Filing Date: May, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 14 2018
Filing of certain prospectuses and communications in connection with business combination transactions
Filing Type: 425Filing Source: edgar
Filing Date: May, 08 2018
Notice of exempt solicitation. Definitive material
Filing Type: PX14A6GFiling Source: edgar
Filing Date: May, 04 2018
Notice of exempt solicitation. Definitive material
Filing Type: PX14A6GFiling Source: edgar
Filing Date: May, 02 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 02 2018
Filing of certain prospectuses and communications in connection with business combination transactions
Filing Type: 425Filing Source: edgar
Filing Date: May, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Filing of certain prospectuses and communications in connection with business combination transactions
Filing Type: 425Filing Source: edgar
Filing Date: May, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018

 

 


Daily Technical Chart for (NASDAQ: ESRX)

Daily Technical Chart for (NASDAQ: ESRX)


Stay tuned for daily updates and more on (NASDAQ: ESRX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ESRX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ESRX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ESRX and does not buy, sell, or trade any shares of ESRX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/